Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1-Reference-Cited by-同舟云学术

Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1

Published:2021-03-15 Issue:7 Volume:35 Page:1061-1072
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Ackerman Peter,Thompson Melanie,Molina Jean-Michel,Aberg Judith,Cassetti Isabel,Kozal Michael,Castagna Antonella,Martins Marcelo,Ramgopal Moti,Sprinz Eduardo,Treviño-Pérez Sandra,Streinu-Cercel Adrian,Latiff Gulam H.,Pialoux Gilles,Kumar Princy N.,Wang Marcia,Chabria Shiven,Pierce Amy,Llamoso Cyril,Lataillade Max

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference24 articles.

1. HIV MDR is still a relevant issue despite its dramatic drop over the years;Armenia;J Antimicrob Chemother,2020

2. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort;Pelchen-Matthews;AIDS,2018

3. Fostemsavir in adults with multidrug-resistant HIV-1 infection;Kozal;N Engl J Med,2020

4. Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in antiretroviral-experienced subjects: week 48 analysis of AI438011, a phase IIb, randomized controlled trial;Thompson;Antivir Ther,2017

5. Activity of the HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068, against CD4-independent viruses and HIV-1 envelopes resistant to other entry inhibitors;Li;Antimicrob Agents Chemother,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study;HIV Medicine;2024-08-25

2. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-05

3. Reassessing the emphasis on limited options in antiretroviral treatment;AIDS;2024-02-29

4. Mechanism of action, resistance, interaction, pharmacokinetics, pharmacodynamics, and safety of fostemsavir;BMC Infectious Diseases;2024-02-23

5. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review;Viruses;2023-08-13